[Use of blood salvage machine in oncologic surgeries: a clinical observation of 13 cases].
OBJECTIVE
To evaluate the effects on blood sparing and risk of hematogenous tumor dissemination of the use of blood salvage machine in oncologic surgeries.


METHODS
The clinical data of 13 patients, 6 with malignant tumors and 7 with benign tumors, who received the use of blood salvage machine during oncologic surgeries based on informed consent, were analyzed.


RESULTS
In total 42,575 ml of packed red blood cells were collected during surgery with a mean value of 3 275 ml (400 - 1500 ml) per patient. The average amount of allogenic transfusion per patient was 1 530 ml (0 - 8,000 ml). The number of blood salvage machine use in oncologic surgeries accounted for 8.6% (13/152) of the total number of blood salvage machine use in surgeries in that period. The perioperative mortality rate of the oncologic surgeries with the use of blood salvage machine was 7.7% (1/13). The post-operative metastasis rate of liver and lung was 15.4% (2/13).


CONCLUSIONS
The use of blood salvage machine during oncologic surgeries improves the blood sparing effect. However, it cannot be used routinely, since it may result in hematogenous tumor cell dissemination.
Guo
Xiang-yang
XY
Department of Anesthesia, Peking Union Medical College Hospital, Beijing 100730, China.
Luo
Ai-lun
AL
Duan
He
H
Chen
Guang-jun
GJ
Ye
Tie-hu
TH
Huang
Yu-guang
YG
Ren
Hong-zhi
HZ
Song
Ya-li
YL
D000328:Adult; D000368:Aged; D016063:Blood Loss, Surgical; D001804:Blood Transfusion, Autologous; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000601:surgery*